Premium
Decreased plasma protein binding of valproate in patients with acute head trauma.
Author(s) -
Anderson GD,
Gidal BE,
Hendryx RJ,
Awan AB,
Temkin NR,
Wilensky AJ,
Winn HR
Publication year - 1994
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1994.tb04304.x
Subject(s) - free fraction , albumin , valproic acid , medicine , anesthesia , anticonvulsant , head trauma , toxicity , plasma protein binding , chemistry , epilepsy , pharmacology , endocrinology , surgery , psychiatry
1. One hundred and ten plasma samples were obtained from 50 patients treated with valproate for prophylaxis of post‐traumatic head injuries. The samples were selected to include a wide range of albumin concentrations and were assayed for free and total valproate concentrations. Valproate binding parameters were determined from the Scatchard equation for one binding site using reweighted least squares analysis. 2. Plasma albumin concentrations were measured in 130 patients with head trauma. They started to decrease immediately after trauma, reaching a minimum at 5‐7 days of approximately 24% of baseline value and did not return to normal until 1 month. 3. The free fraction of valproate varied six to seven‐fold as albumin concentration ranged from 1.5 to 4.8 g 100 ml‐1 (218‐696 mumol l‐1). The mean association constant for binding (Ka) was 0.008 mumol l(‐1) and the mean number of binding sites (N) was 2.0. There values were similar to those reported for valproate in otherwise healthy patients with epilepsy. 4. Because of saturable protein binding of valproate, hypoalbuminaemia may necessitate the monitoring of free valproate concentrations to avoid toxicity when valproate is used in patients with acute head injury.